Anna Egorova - Search Results

Year	Number of Results
2009	1
2011	1
2012	1
2013	2
2014	1
2016	3
2017	1
2018	5
2019	5
2020	7
2021	4

1

Nitric oxide-releasing compounds for the treatment of lung infections.

Chiarelli LR, Degiacomi G, Egorova A, Makarov V, Pasca MR. Chiarelli LR, et al. Among authors: egorova a. Drug Discov Today. 2020 Nov 9:S1359-6446(20)30463-3. doi: 10.1016/j.drudis.2020.10.027. Online ahead of print. Drug Discov Today. 2020. PMID: 33181094 Review.

2

Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.

Egorova A, Ekins S, Schmidtke M, Makarov V. Egorova A, et al. Eur J Med Chem. 2019 Sep 15;178:606-622. doi: 10.1016/j.ejmech.2019.06.008. Epub 2019 Jun 11. Eur J Med Chem. 2019. PMID: 31226653 Review.

3

Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity.

Monakhova N, Korduláková J, Vocat A, Egorova A, Lepioshkin A, Salina EG, Nosek J, Repková E, Zemanová J, Jurdáková H, Górová R, Roh J, Degiacomi G, Sammartino JC, Pasca MR, Cole ST, Mikušová K, Makarov V. Monakhova N, et al. Among authors: egorova a. ACS Infect Dis. 2021 Jan 8;7(1):88-100. doi: 10.1021/acsinfecdis.0c00622. Epub 2020 Dec 22. ACS Infect Dis. 2021. PMID: 33352041

4

Dispirotripiperazine-core compounds, their biological activity with a focus on broad antiviral property, and perspectives in drug design (mini-review).

Egorova A, Bogner E, Novoselova E, Zorn KM, Ekins S, Makarov V. Egorova A, et al. Eur J Med Chem. 2021 Feb 5;211:113014. doi: 10.1016/j.ejmech.2020.113014. Epub 2020 Nov 12. Eur J Med Chem. 2021. PMID: 33218683 Free PMC article. Review.

5

Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates.

Maretina MA, Zheleznyakova GY, Lanko KM, Egorova AA, Baranov VS, Kiselev AV. Maretina MA, et al. Among authors: egorova aa. Curr Genomics. 2018 Aug;19(5):339-355. doi: 10.2174/1389202919666180101154916. Curr Genomics. 2018. PMID: 30065610 Free PMC article. Review.

6

The Evolution of Pleconaril: Modified O-Alkyl Linker Analogs Have Biological Activity towards Coxsackievirus B3 Nancy.

Volobueva A, Egorova A, Galochkina A, Ekins S, Zarubaev V, Makarov V. Volobueva A, et al. Among authors: egorova a. Molecules. 2020 Mar 16;25(6):1345. doi: 10.3390/molecules25061345. Molecules. 2020. PMID: 32188089 Free PMC article.

7

The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants.

Balobanov V, Chertkova R, Egorova A, Dolgikh D, Bychkova V, Kirpichnikov M. Balobanov V, et al. Among authors: egorova a. Biomolecules. 2020 Feb 5;10(2):241. doi: 10.3390/biom10020241. Biomolecules. 2020. PMID: 32033353 Free PMC article.

8

VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier.

Egorova AA, Maretina MA, Kiselev AV. Egorova AA, et al. Methods Mol Biol. 2019;1974:57-68. doi: 10.1007/978-1-4939-9220-1_5. Methods Mol Biol. 2019. PMID: 31098995

9

Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes.

Egorova AA, Shtykalova SV, Maretina MA, Sokolov DI, Selkov SA, Baranov VS, Kiselev AV. Egorova AA, et al. Pharmaceutics. 2019 Jun 6;11(6):261. doi: 10.3390/pharmaceutics11060261. Pharmaceutics. 2019. PMID: 31174285 Free PMC article.

10

Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells.

Egorova A, Selutin A, Maretina M, Selkov S, Baranov V, Kiselev A. Egorova A, et al. Pharmaceuticals (Basel). 2020 Oct 10;13(10):300. doi: 10.3390/ph13100300. Pharmaceuticals (Basel). 2020. PMID: 33050526 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results